Following our successful advocacy campaign during the last three months of 2020 which led to a six-month delay in implementation of the new PMPRB Regulations – now set to come into force on July 1, 2021 – we promised you we would keep our eyes on this important issue....
Our message was heard! On December 30, 2020 – just two days before the new PMPRB Guidelines were due to come into force – the Government of Canada advised stakeholders that implementation of the amended Patented Medicines Regulations has been further delayed...
NEWS RELEASE: Federal Government Must Delay Drug Pricing Reform to Safeguard Patient Lives During COVID-19 Today, the Canadian Association of PNH Patients, issued a news release pressing the Federal government to again delay the implementation of the new PMPRB...
On November 6, PNH Canada submitted a brief to the House of Commons Standing Committee on Health (HESA) to inform the study it is undertaking on the Final Guidelines issued by the Patented Medicine Prices Review Board (PMPRB) on October 23, 2020. Our submission...
Thank you for participating in the #stopPMPRBnow campaign by emailing and tweeting to federal decision makers and sharing our campaign with your networks. For those who have not yet had a chance, we urge you to join us today and lend your voice to this important...
We urgently need your help – and the help of your personal and professional networks – to #stopPMPRBnow! Please follow the six (6) easy steps below to send out the “Friends & Family” email to encourage others to join our campaign – their participation is critical...
On October 1, 2020, the Canadian Association of PNH Patients officially launched its #stopPMPRBnow advocacy campaign due to concerns regarding the proposed amendments to the Regulations governing the Patented Medicine Prices Review Board (PMPRB) set to come into...
Click on any of the Tweets below to contact decision makers (you must be logged in to Twitter).
